Evidence map›Paper›PMID 20218584›Full record

ArticleAnalytical chemistry2010

A rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC/MS and its application for accurate and sensitive quantification of carbonyl reductases in human liver.

Jin Cao, Vanessa Gonzalez-Covarrubias, Vanessa M Covarrubias, Robert M Straubinger, Hao Wang, Xiaotao Duan, Haoying Yu, Jun Qu, Javier G Blanco

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
    Covarrubias, Vanessa M [corrected to Gonzalez-Covarrubias., Vanessa]
5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jin CaoThe Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, New York 14260, USA.
Vanessa Gonzalez-Covarrubias
Vanessa M Covarrubias
Robert M Straubinger
Hao Wang
Xiaotao Duan
Haoying Yu
Jun Qu
Javier G Blanco
University at Buffalo, State University of New York · US

Funding

PHARMACOGENETICS OF HUMAN CARBONYL REDUCTASESR01GM073646 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BLANCO, JAVIER GUILLERMO · 2005 to 2019
$4.1M
Peripheral biomarkers of cocaine dependence and relapseR21DA027528 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI QU, JUN, STRAUBINGER, ROBERT M · 2009 to 2010
$631k
High sensitivity liquid chromatography tandem mass spectrometry systemS10RR023650 · NCRR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI STRAUBINGER, ROBERT M · 2007 to 2007
$500k
LC/QUADRUPOLE ION TRAP MASS SPECTROSCOPY SYSTEM: PROTEOMICSS10RR021221 · NCRR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI STRAUBINGER, ROBERT M · 2005 to 2005
$319k
High Performance Computational System to Support LCMS/Proteomics AnalysisS10RR024521 · NCRR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI STRAUBINGER, ROBERT M · 2009 to 2009
$238k
NCRR NIH HHS S10 RR021221NCRR NIH HHS S10 RR023650NCRR NIH HHS S10 RR024521NIDA NIH HHS 1R21DA027528NIDA NIH HHS R21 DA027528NIGMS NIH HHS GM73646NIGMS NIH HHS R01 GM073646
6 · The paper itself

Abstract

Liquid chromatography (LC)/mass spectrometry (MS) in selected-reactions-monitoring (SRM) mode provides a powerful tool for targeted protein quantification. However, efficient, high-throughput strategies for proper selection of signature peptides (SP) for protein quantification and accurate optimization of their SRM conditions remain elusive. Here we describe an on-the-fly, orthogonal array optimization (OAO) approach that enables rapid, comprehensive, and reproducible SRM optimization of a large number of candidate peptides in a single nanoflow-LC/MS run. With the optimized conditions, many peptide candidates can be evaluated in biological matrixes for selection of the final SP. The OAO strategy employs a systematic experimental design that strategically varies product ions, declustering energy, and collision energy in a cycle of 25 consecutive SRM trials, which accurately reveals the effects of these factors on the signal-to-noise ratio of a candidate peptide and optimizes each. As proof of concept, we developed a highly sensitive, accurate, and reproducible method for the quantification of carbonyl reductases CBR1 and CBR3 in human liver. Candidate peptides were identified by nano-LC/LTQ/Orbitrap, filtered using a stringent set of criteria, and subjected to OAO. After evaluating both sensitivity and stability of the candidates, two SP were selected for quantification of each protein. As a result of the accurate OAO of assay conditions, sensitivities of 80 and 110 amol were achieved for CBR1 and CBR3, respectively. The method was validated and used to quantify the CBRs in 33 human liver samples. The mean level of CBR1 was 93.4 +/- 49.7 (range: 26.2-241) ppm of total protein, and of CBR3 was 7.69 +/- 4.38 (range: 1.26-17.9) ppm. Key observations of this study: (i) evaluation of peptide stability in the target matrix is essential for final selection of the SP; (ii) utilization of two unique SP contributes to high reliability of target protein quantification; (iii) it is beneficial to construct calibration curves using standard proteins of verified concentrations to avoid severe biases that may result if synthesized peptides alone are used. Overall, the OAO method is versatile and adaptable to high-throughput quantification of validated biomarkers identified by proteomic discovery experiments.

Indexed as

Alcohol OxidoreductasesAmino Acid SequenceChromatography, High Pressure LiquidHumansLiverMass SpectrometryProtein Structure, TertiaryReproducibility of ResultsAlcohol Oxidoreductases

Identifiers

PMID20218584
PMCPMC2883886
OpenAlexW1963568555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.